Selective laser trabeculoplasty (SLT) offers good long-term reductions in intraocular pressure (IOP), according to the results of a study performed by Rahul Yadav, MD and colleagues of the Mid Yorkshire Hospitals NHS Trust, Wakefield, UK.
Study assesses efficacy of cyclosporine A 0.1% cationic emulsion drops for postoperative discomfort
Prophylactic cyclosporine A 0.1% eye drops were associated with improved ocular surface homeostasis and reduced inflammation
Higher Molar Dose and Its Translation into Clinical Practice
Study links new gender and genetic factors to Fuchs Endothelial Corneal Dystrophy
A large-scale study indicates women are more likely to develop the inherited corneal condition
Her Royal Highness The Duchess of Edinburgh delivers keynote address on gender equity in eye care
The UN Friends of Vision group meeting coincided with International Women's Day and the UN Commission on the Status of Women
Advanced therapies in neovascular AMD and DMO: Experts weigh in
A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden
OKYO Pharma files US FDA Fast Track application for neuropathic corneal pain treatment urcosimod
Urcosimod, formerly known as OK-101, showed clear statistical significance in multiple endpoints in a recently completed Phase 2 trial